The 235-kDa antigenic rhoptry protein Py235 of Plasmodium yoelii is encoded by a large, highly polymorphic gene family. Monoclonal antibodies to some of these antigens have been shown to attenuate the virulence of the lethal YM strain of the parasite, converting a potentially fatal YM infection to a fulminating one typical of the nonlethal 17X strain, by inducing a switch in target cell preference from mature red blood cells to reticulocytes. The reason for this is not known but would suggest that antigenic determinants of Py235 may be useful in or as subunit vaccines. To identify such determinants, we constructed an epitope expression library of one Py235 variant and screened the library with the antibodies. Thus, we mapped 5-and 12-amino acid epitopes to the C-terminus of the antigen. Both epitopes were more reactive with protective than with nonprotective monoclonal antibodies. This may explain the differential protection conferred by these antibodies upon their passive transfer into mice.
Introduction
There are multiple Py235 isoforms of Plasmodium yoelii ensconced within the merozoite rhoptry organelle; these are encoded by a differentially transcribed, highly polymorphic gene family that comprises up to 14 copies within the haploid parasite genome (Keen et al., 1990 (Keen et al., , 1994 Khan et al., 2001; Bayele & Brown, 2007) . Our interest in Py235 is predicated on observations that passive transfer of monoclonal antibodies to this antigen attenuates parasite virulence and protects mice against fatal infection by the lethal strain P. yoelii YM, by apparently restricting the parasites to immature red cells (Freeman et al., 1980; Holder & Freeman, 1981) . This suggests that Py235 may be a paradigm for vaccine development against the human parasite orthologue of Py235. However, to do this it is important to delineate those antigenic determinants or epitopes that evoke host immune response(s). As a first step, we isolated a number of these variants by expression cloning using monoclonal antibodies as probes (Bayele & Brown, 2007) . In this report, we take these initial findings further to identify the cognate epitopes.
Epitope-mapping may be achieved with peptides generated by proteolysis, chemical cleavage, and with overlapping synthetic peptides (Langerbeheim et al., 1976; Atassi, 1984; Tanier et al., 1984; Berzofsky, 1985; Geysen et al., 1987) . Bioinformatic algorithms have also been employed; these predict B-cell epitopes and their antigenicity based on the atomic mobility, accessibility and hydrophilicity of the constituent amino acids and their propensities to be exposed and to form b-turns (Hopp & Woods, 1983; Westhof et al., 1984; Krchnak et al., 1987; Bhat et al., 1990; Nicholson, 1994) . These methods have been superseded and/or complemented by the use of lambda (Young & Davis, 1983) , phagemid vectors and filamentous phage as surrogates for surface display of antigenic sites which can then be identified with the relevant antibodies (Smith, 1985; Parmley & Smith, 1988) . Transposon mutagenesis has also been successfully used to map epitopes; this method relies on the efficient conjugal transfer of transposons between permissive Escherichia coli hosts, and their integration and interruption of target epitopes within the cDNA encoding the antigen of interest (Sedgewick et al., 1991) .
In this report we describe a rapid and simple procedure for generating an antigen-specific epitope library which enabled us to define 5-and 12-amino acid (continuous) epitopes on one variant of Py235. Our results may provide a molecular basis for Py235 antibody binding specificity, and a method to characterize Py235 orthologues in Plasmodium falciparum in terms of antibody recognition.
Materials and methods

Expression of recombinant antigen and Western blotting
Py235-18, previously identified by expression cloning (Bayele & Brown, 2007) , was selected for epitope-mapping in this study. The cDNA ($1.46 kb) was subcloned by PCR into pCRII (Invitrogen) as a transcriptional fusion with the lac promoter and in-frame with the lacZa fragment, and verified by partial sequencing. The resulting construct p235-18 was used to transform competent DH5a cells (Invitrogen). For expression, transformants were grown to mid-log phase in 50 mL LB with 100mg mL À1 ampicillin and induced with 2 mM final concentration of isopropyl-b-D-thiogalactopyranoside, IPTG (Invitrogen). After 5 h at 37 1C, the cells were centrifuged at 16 000 g for 10 min, and resuspended in lysis buffer (50 mM Tris-Cl pH 8.0, 10 mM EDTA, 150 mM NaCl, 0.05% Triton-X100, 1 mM phenylmethylsulphonyl fluoride (PMSF) and 200 mg mL À1 lysozyme). The cell lysate was incubated for 30 min at room temperature after adding 10 mg mL À1 DNase I (Roche) to reduce viscosity. The lysate was centrifuged for 10 min at 4 1C and aliquots of the supernatant were electrophoresed in triplicates on a 10% SDS-PAGE gel. After electrophoresis, the proteins were blotted onto Immobilon-P membranes (Millipore) using a semi-dry blotter (Millipore). The membrane was cut into strips and blocked with Tris-buffered saline, 0.05% Tween (TBST) and 1% bovine serum albumin (BSA) for 1 h at room temperature. The strips were then separately incubated with monoclonal antibodies 25.37, 25.77 and 25.86. After 1 h incubation at room temperature, they were washed 3X with TBST and incubated with horseradish peroxidaseconjugated anti-mouse secondary antibody (Amersham Pharmacia Biotech). After washing the membranes, antigen was detected with the ECL system (Amersham) as suggested by the manufacturer, and exposed to Hyperfilm (Amersham).
Construction of epitope library
Py235-18 was digested with EcoRI and resolved on a 0.8% low melting point agarose (Sigma). The insert was purified by phenol:chloroform extraction and ethanol precipitation, and digested for 10 min with 15 U mL À1 DNase 1 (Roche) at 37 1C in 0.5X Universal buffer (Stratagene). The resulting fragments were phenol:chloroform-extracted and treated for 15 min with 10 U of T4 DNA polymerase (New England Biolabs) and dNTPs (200 mM final concentration) in 1X Universal buffer. Thereafter 4 U of Klenow enzyme (Roche), 20 U T4 polynucleotide kinase (New England Biolabs) and ATP (1 mM final concentration) were added and incubation was continued at 37 1C for another 30 min after adjusting the reaction buffer concentration accordingly. The DNA was purified by phenol : chloroform extraction and ethanol precipitation, and resuspended in 20 mL 10 mM Tris, 1 mM EDTA, TE (pH 8.0). Terminal deoxynucleotidyl transferase buffer was added together with 30 U of the enzyme (Invitrogen) and 100 mM dideoxy ATP, ddA. The reaction volume was made up to 50 mL with sterile distilled water, and incubated for 45 min at 37 1C. The reaction mixture was phenol:chloroform-extracted, ethanol-precipitated and resuspended in 20 mL TE. The DNA was ligated into pCRII using the Rapid Ligation kit (Roche) as instructed by the manufacturer; an aliquot of the ligation was used to transform DH5a competent cells to generate the epitope library.
Epitope expression cloning and sequencing
An aliquot of the epitope library was spread on LB agar plates containing 10 mM IPTG and 100 mg mL À1 ampicillin.
After colony growth, Immobilon-P membrane presoaked in 10 mm IPTG was laid on the plates for a further 6 h. The colonies were lifted and lysed in an atmosphere of chloroform as described previously (Harlow & Lane, 1988; Bayele & Brown, 2007) . After blocking the membrane with 5% nonfat dry milk in TBST for 1 h at room temperature, a cocktail of the monoclonal antibodies 25.37, 25.77 and 25.86 was added and incubated for 2 h at room temperature. The membrane was washed with TBST (3 Â 5 min) and probed with alkaline phosphatase-conjugated mouse IgG (Sigma) for 1 h at room temperature. After washing the membrane with TBST as above, colonies expressing the epitope(s) were identified by incubating with the NBT/BCIP substrate Sigma Fast (Sigma). Plasmid DNA was purified from bacterial cultures of putative positive colonies and sequenced with Sequenase (Amersham Pharmacia Biotech) using T7 promoter and M13 reverse sequencing primers. Sequencing reactions were resolved on 6% denaturing polyacrylamide gels (National Diagnostics).
Peptide synthesis and ELISA
Peptides corresponding to the epitope sequences were synthesized on an Applied Biosystems synthesizer model 430A. They were dissolved in sterile distilled water at a concentration of 1 mg mL À1 and diluted in 100 mM bicarbonate buffer (pH 9.6). Various dilutions (100 mL each, in duplicate) of the peptides were adsorbed onto 96-well Covalink ELISA plates (Nunc) by incubating overnight at 4 1C. The wells were washed five times with TBST on an automated microplate washer (Denley), and nonspecific sites were blocked with 5% BSA in TBST. After 1 h incubation at room temperature, the wells were again washed 5X with TBST; the above monoclonal antibodies were added separately to each well at a 1 : 1000 dilution in blocking buffer. Unbound antibody was removed by washing 5X with TBST 2 h after incubation at 37 1C. Alkaline phosphate-conjugated anti-mouse IgG (Sigma) was added to the wells at a 1 : 44 000 dilution in 5% BSA in TBST and incubated for another 2 h. After a repeat washing with TBST, 100 mL Sigma Fast p-nitrophenyl phosphate dissolved in TBST was added to each well. The plates were incubated at 37 1C for colour development, and absorbances were measured at 405 nm.
Dot-blotting
Various amounts of the epitope peptides were immobilized on strips of Immobilon-P membranes using a dot-blotter (Schleicher & Schuell). The membrane strips were processed for reactivity by probing them separately with the antibodies, and detected with the ECL system.
Nucleotide sequence accession
Sequence data reported in this paper is available in the GenBank TM , EMBL and DDBJ databases under the accession number AJ311088.
Results
Construction of antigen-specific epitope library and epitope mapping
We previously described the expression cloning of antigenic variants of Py235 (Bayele & Brown, 2007) using monoclonal antibodies as probes. To assess antigen-antibody interaction further, one of the strongly immunoreactive clones (Py235-18), encoding a partial sequence of the antigen and spanning the last fifth of the total coding capacity of the gene, was selected for further study. Fusion protein expression and Western blotting showed that the antibodies bound differentially to the antigen in the order: 25.37 4 25.77 4 25.86 (Fig. 1) .
To map epitopes recognized by the monoclonal antibodies, Py235-18 was digested with DNase 1 to produce 15-50 oligonucleotides which were then tailed with ddA. This ensured that only one nucleotide was added to the 3 0 end of the fragments. This approach derives from the chainterminating ability of dideoxyribonucleotides due to their lack of 3 0 OH groups and therefore a termination in chain elongation. By using ddA, a complementary nucleotide was thus incorporated for ligation of the DNase 1 fragments into the PCR cloning T-vector pCRII thus generating an epitope library which was used to transform DH5a cells (Fig. 2a) . The library was screened with a cocktail of the antibodies 25.37, 25.77 and 25.86 rather than individually, based on the presumption that Py235 would be exposed to all these antibodies simultaneously in vivo. Thus two strongly reactive clones were identified (Fig. 2b) and sequenced (Fig. 2c) ; these encoded 12 amino acids (epitope 1, NLIE-SEHSNNNN) and five amino acids (epitope 2, AVNDT). These sequences were identical, both in spatial arrangement and sequence content, to those in the original Py235-18 cDNA clone, indicating that no rearrangements or adventitious sequences were inadvertently added (by ddA tailing) during construction of the epitope library.
Sequence analyses
Sequence comparisons (Corpet, 1988) showed that Py235-18 was homologous to the two previously characterized variants E3 and E8 (Keen et al., 1990 (Keen et al., , 1994 . Where differences occurred, they were largely restricted to conservative substitutions although some nonconservative substitutions were found including those within the two defined epitopes (Fig. 3a) . Comparison of the two epitope peptide sequences showed that they were homologous over a 4-amino acid overlap; this homology was based on the conservative substitutions L/V, E/D, S/T (Fig. 3b) . The most important differences between epitope 1 and homologous sequences in E3, E8 or in other antigenic variants are shown in Fig. 3c . The two epitopes are separated by 102 amino acids. Deletions of 27 and 36 bp in E3 and E8, respectively, have resulted in the absence of epitope 2 within variants encoded by these genes. However, this epitope is partially homologous to a repetitive tripeptide motif (aspartic acid/ isoleucine/asparagine; DIN) that occurs at the C-termini of both E3 and E8. This epitope also contains a potential Nglycosylation site (NDT motif), but it is not clear if it is indeed glycosylated in vivo. Hydropathy plots showed that the region encompassing the epitopes is hydrophilic and accessible (Fig. 3d) ; these two parameters are key determinants of antigenicity (Bittle et al., 1982; Hopp & Woods, 1983; Atassi, 1984; Berzofsky, 1985; Krchnak et al., 1987) .
Differential reactivity of epitopes with monoclonal antibodies
By both dot-blots and ELISA, we found that the two epitopes were differentially reactive with the three monoclonal antibodies. Whereas both epitopes were recognized by the protective antibodies 25.37 and 25.77, there was little binding by the nonprotective antibody 25.86 either by dotblotting (Fig. 4a) or by ELISA (Fig. 4b) . In addition, preimmune mouse serum did not bind to either epitope (data not shown). The order of antibody recognition for both epitopes was 25.37 4 25.77 4 25.86. This order of reactivity supports the Western blot data using expressed full-length Py235-18 fusion protein.
Discussion
We previously contributed new information on how P. yoelii may express multiple variants of the Py235 rhoptry antigen during infection (Bayele & Brown, 2007) . Other work had also shown that the parasite was unable to replicate when mice were immunized with antibodies to this antigen (Freeman et al., 1980; Holder & Freeman, 1981) . Our aim in this report was to map the immunogenic regions of the antigen(s) to which these antibodies bind, to understand how these antibodies may be protective in vivo. Thus, one variant Py235-18 was selected for epitope-mapping using the cognate monoclonal antibodies. A fusion protein of this variant was found to bind the antibodies differentially. We next constructed an epitope library of Py235-18, from which two strongly reactive clones encoding 5 and 12 amino acid peptides were isolated. These peptides were also differentially recognized by the two protective antibodies 25.37 and 25.77 as determined by ELISA and dot-blotting; in contrast there was little binding of the nonprotective antibody 25.86 to either epitope. As the epitopes are not identical, it is not clear why they were both recognized by different antibodies. This may imply that heterogeneous cross-reacting antibodies may be mounted in response to Py235 variants in vivo. Such antibodies may have the same specificity but with differing affinities for the antigen as seen in both Western and dot-blots, and in ELISAs. Epitope 2 is encoded by a polymorphic and potentially unstable DNA segment (Bittle et al., 1982) ; this segment has largely been deleted from other members of the gene family (Khan et al., 2001) . Interestingly, fusion proteins derived from that segment of E3 and E8 were not recognized by the antibodies (S. Ogun, pers. commun.) ; this may be explained by the absence of epitope 2 in both clones. The uniqueness of this epitope in Py235-18 suggests that it may be immunologically and functionally important. In spite of the relative conservation of epitope 1 between E3, E8 and Py235-18, it is possible that the antigenicity of this epitope could be ascribed to critical amino acids (Fig. 3c) . Antibody binding specificity can be determined by single amino acid substitutions, and this underlies differences in antigenicity between the merozoite surface proteins of the AS and CB strains of Plasmodium chabaudi (McKean et al., 1993) .
From the inception of this study, our working assumption was that specific regions of Py235 may act as binding sites for normocyte recognition and invasion. This view is supported by observations that Py235 binds red blood cells (Ogun et al., 2000) and is also consistent with the recent cloning of P. falciparum orthologues of Py235, PfRh. These genes confer phenotypic variation and are involved in a novel red cell invasion pathway (Taylor et al., 2002; Duraisingh et al., 2003; Triglia et al., 2005) . Our work may therefore provide a basis for delineating the relevant epitopes in PfRH for downstream functional analyses. Until then, however, a few issues remain unanswered. For example, it is unclear whether the identified epitopes are variable within a clonal inoculum of parasites or whether individual parasites are capable of expressing different epitopes simultaneously during an infection cycle. Although we have also shown antibody reactivity with the epitopes in vitro, it is still not certain whether these epitopes can induce a protective immune response in vivo. Work in progress will determine if this is the case. Epitope peptides (up to 10 mg each) were blotted onto Immobilon-P membranes and screened separately with monoclonal antibodies 25. 37, 25.77 and 25.86. (b) ELISA. Peptides were screened with the above antibodies as described above; epitopes are denoted by a prefix (1, for epitope 1, and 2, for epitope 2), followed by the last two numerals of the antibody designation (i.e. 1.37, 1.77, 1.86; 2.37, 2.77 and 2.86).
